Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 20, 2023

BUY
$49.7 - $57.71 $13,468 - $15,639
271 Added 5.77%
4,965 $0
Q3 2022

Nov 15, 2022

SELL
$53.86 - $66.8 $4,739 - $5,878
-88 Reduced 1.84%
4,694 $253,000
Q2 2022

Aug 08, 2022

BUY
$63.83 - $80.0 $16,148 - $20,240
253 Added 5.59%
4,782 $307,000
Q1 2022

May 02, 2022

SELL
$76.85 - $89.45 $21,133 - $24,598
-275 Reduced 5.72%
4,529 $351,000
Q4 2021

Jan 26, 2022

BUY
$74.57 - $87.19 $73,078 - $85,446
980 Added 25.63%
4,804 $412,000
Q2 2021

Aug 06, 2021

SELL
$80.5 - $88.01 $4,830 - $5,280
-60 Reduced 1.54%
3,824 $308,000
Q1 2021

May 11, 2021

BUY
$76.38 - $86.03 $12,679 - $14,280
166 Added 4.46%
3,884 $328,000
Q4 2020

Feb 12, 2021

BUY
$75.39 - $82.36 $22,240 - $24,296
295 Added 8.62%
3,718 $298,000
Q3 2020

Nov 09, 2020

BUY
$78.33 - $90.73 $12,141 - $14,063
155 Added 4.74%
3,423 $275,000
Q2 2020

Aug 11, 2020

BUY
$78.66 - $94.14 $23,204 - $27,771
295 Added 9.92%
3,268 $281,000
Q1 2020

May 13, 2020

BUY
$71.57 - $93.3 $3,220 - $4,198
45 Added 1.54%
2,973 $241,000
Q4 2019

Feb 03, 2020

BUY
$76.7 - $88.45 $2,147 - $2,476
28 Added 0.97%
2,928 $245,000
Q3 2019

Mar 06, 2020

BUY
$81.4 - $89.78 $4,070 - $4,489
50 Added 1.75%
2,900 $254,000
Q2 2019

Mar 02, 2020

SELL
$73.44 - $82.41 $15,128 - $16,976
-206 Reduced 6.74%
2,850 $233,000
Q1 2019

Mar 02, 2020

BUY
$64.48 - $81.31 $197,050 - $248,483
3,056 New
3,056 $248,000
Q4 2018

Feb 25, 2020

SELL
$61.45 - $77.8 $165,361 - $209,359
-2,691 Closed
0 $0
Q3 2018

Feb 25, 2020

SELL
$70.71 - $77.75 $43,415 - $47,738
-614 Reduced 18.58%
2,691 $207,000
Q2 2018

Feb 11, 2020

BUY
$63.43 - $75.41 $2,220 - $2,639
35 Added 1.07%
3,305 $244,000
Q1 2018

Jan 30, 2020

BUY
$62.56 - $72.26 $2,627 - $3,034
42 Added 1.3%
3,270 $213,000
Q4 2017

Jan 30, 2020

BUY
$61.45 - $66.05 $198,360 - $213,209
3,228
3,228 $209,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $14.9B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Verdence Capital Advisors LLC Portfolio

Follow Verdence Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verdence Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verdence Capital Advisors LLC with notifications on news.